US$ 24.87
glutathione metabolism in cancer progression and treatment resistance Targeting glutamine as a therapeutic strategy for Glutathione-Dependent Pathways in Cancer Cells
Description
control vs SCI+GlyNAC, P = 0.9764

Tirzeptatide versus semaglutide for weight loss in patients with type 2 diabetes mellitus: A value for money analysis

doi: 10.1002/biof.5520120102

Novel formulations: A groundbreaking phase I trial (NCT04877274) evaluates a cinnamaldehyde-based prodrug nanosystem, leveraging FDA-approved food additives for anti-inflammatory effects with reduced hepatotoxicity
